Skip to content

    Osteoporosis Health Center

    Font Size

    Bone-Building Drugs May Also Beef Up Cartilage

    WebMD Health News
    Reviewed by Gary D. Vogin, MD

    June 15, 2001 -- A drug being developed to prevent the breakdown of bone caused by a type of cancer may also be able to prevent or slow the deterioration of cartilage in joints, a condition that can lead to painful and disabling osteoarthritis and rheumatoid arthritis, report French researchers in a small study published in the May issue of the journal Bone.

    In a study of 26 patients with Paget's disease of bone, a disorder marked by breakdown of bone and abnormal attempts by the body to repair it, the drug Zometa appeared to at least partially prevent the deterioration of type II collagen, the protein that is the primary component of cartilage in joints.

    Their findings suggest that Zometa and similar drugs used to treat osteoporosis and related conditions may also have a protective effect on cartilage in general, say Patrick Garnero, MD, and colleagues with the French National Institute of Health and Medical Research.

    Zometa belongs to a class of drugs known as bisphosphonates, which includes the FDA-approved osteoporosis drugs Actonel and Fosamax; Zometa has not been approved for either osteoporosis or Paget's disease but may be in the near future, according to a spokesperson for the Paget Foundation. Currently, its intended purpose is the aforementioned treatment of a condition brought about by cancer that has spread to bones.

    Throughout life, new bone is constantly being formed by cells called osteoblasts; the bone-building action is balanced by bone breakdown or "resorption," which is performed by another class of cells called osteoclasts. Paget's disease and osteoporosis are caused by an imbalance in the bone formation/breakdown cycle. Bisphosphonates help to preserve bone by interfering with the action of osteoclasts, thereby allowing a more normal bone growth pattern to occur.

    Because studies of bisphosphonates in animals had suggested that the drugs could also have an effect on the formation of joint tissues, Garnero and colleagues looked for evidence of a similar effect on cartilage in humans. They looked for signs of type II collagen destruction in the urine of 26 patients with Paget's disease and a comparison group, both before and after a single injection of either Zometa or a placebo.

    Today on WebMD

    Women working out and walking with weights
    Reduce bone loss and build stronger muscles.
    Chinese cabbage
    Calcium-rich foods to add to your diet.
    woman stretching
    Get the facts on osteoporosis.
    Porous bone
    Causes, symptoms, risk factors, and treatment.
    senior woman
    Woman holding plate of brocolli
    wrist xray
    Superfood for Bones
    mature woman
    sunlight in hands
    man and woman in front of xray
    woman with dumbbells